Bellevue Group Ag Blueprint Medicines Corp Transaction History
Bellevue Group Ag
- $5.98 Billion
- Q2 2024
A detailed history of Bellevue Group Ag transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Bellevue Group Ag holds 5,100 shares of BPMC stock, worth $471,545. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,100
Previous 5,100
-0.0%
Holding current value
$471,545
Previous $483,000
13.66%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding BPMC
# of Institutions
340Shares Held
62MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$615 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$605 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$543 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$299 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$227 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.52B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...